Figure 5. Dose Reduction Index (DRI) of doxorubicin (DOX).
L-Canavanine (L-CAV) was combined with DOX using a constant ratio in two types of cells, cells with high ASS expression (HeLa and Caco-2) and cells with low ASS expression (MIA PaCa-2, BxPC-3, Hep G2, and SK-HEP-1).